108 related articles for article (PubMed ID: 10470436)
21. Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer.
Livingston RB; Ellis GK; Gralow JR; Williams MA; White R; McGuirt C; Adamkiewicz BB; Long CA
J Clin Oncol; 1997 Apr; 15(4):1395-400. PubMed ID: 9193331
[TBL] [Abstract][Full Text] [Related]
22. Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer.
Goss PE; Fine S; Gelmon K; Rudinskas L; Ottaway J; Myles J; James K; Paul K; Rodgers A; Pritchard KI
Cancer Chemother Pharmacol; 1997; 41(1):53-60. PubMed ID: 9443614
[TBL] [Abstract][Full Text] [Related]
23. Phase I study of weekly vinorelbine in combination with weekly paclitaxel in adult patients with advanced refractory cancer.
Cohen RB; Mueller SC; Haden K; de Souza P
Cancer Invest; 2000; 18(5):422-8. PubMed ID: 10834026
[TBL] [Abstract][Full Text] [Related]
24. Final results of a phase I/II pilot study of capecitabine with or without vinorelbine after sequential dose-dense epirubicin and paclitaxel in high-risk early breast cancer.
Müller V; Thomssen C; Schmidt M; Glados M; Jackisch C; Heilmann V; Hinke A; Lehnert A; Borowicz H; Möbus V
BMC Cancer; 2010 Aug; 10():430. PubMed ID: 20712886
[TBL] [Abstract][Full Text] [Related]
25. Capecitabine and vinorelbine in elderly patients (> or =65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99).
Hess D; Thürlimann B; Pagani O; Aebi S; Rauch D; Ballabeni P; Rufener B; Castiglione-Gertsch M; Goldhirsch A;
Ann Oncol; 2004 Dec; 15(12):1760-5. PubMed ID: 15550580
[TBL] [Abstract][Full Text] [Related]
26. Sequential therapy in advanced non-small-cell lung cancer with weekly paclitaxel followed by cisplatin-gemcitabine-vinorelbine. A phase II study.
Feliu J; Martin G; Lizón J; Chacón JI; Dorta J; de Castro J; Rodríguez A; Sánchez Heras B; Torrego JC; Espinosa E; González Barón M;
Ann Oncol; 2001 Oct; 12(10):1369-74. PubMed ID: 11762806
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and toxicity of vinorelbine with doxorubicin/cyclophosphamide combination chemotherapy in a phase I-II study for advanced or recurrent breast cancer patients.
Saeki T; Takashima S; Ogita M; Tabei T; Adachi I; Tamura K; Takatsuka Y; Kanda K
Breast Cancer; 2006; 13(2):159-65. PubMed ID: 16755111
[TBL] [Abstract][Full Text] [Related]
28. Phase I study of vinorelbine and docetaxel with granulocyte colony-stimulating factor support in the treatment of metastatic breast cancer.
Ibrahim NK; Rahman Z; Valero V; Murray JL; Frye D; Hortobagyi GN
Cancer Invest; 2002; 20(1):29-37. PubMed ID: 11852999
[TBL] [Abstract][Full Text] [Related]
29. Full dose paclitaxel plus vinorelbine as salvage chemotherapy in anthracycline-resistant advanced breast cancer: a phase II study.
Polyzos A; Tsavaris N; Kosmas C; Gogas H; Toufexi H; Kosmidis C; Markopoulos C; Giannopoulos A; Papadopoulos O; Stamatiadis D; Kouraklis G
J Chemother; 2003 Dec; 15(6):607-12. PubMed ID: 14998089
[TBL] [Abstract][Full Text] [Related]
30. Combination chemotherapy with docetaxel plus vinorelbine in metastatic breast cancer patients with prior exposure to anthracyclines.
Martí JL; Bueso P; Mayordomo JI; Isla MD; Saenz A; Escudero P; Murillo L; Filipovich E; Andres R; Tres A
Ann Oncol; 2001 Aug; 12(8):1061-5. PubMed ID: 11583186
[TBL] [Abstract][Full Text] [Related]
31. First-line chemotherapy with vinorelbine and paclitaxel as simultaneous infusion in advanced breast cancer.
Vici P; Amodio A; Di Lauro L; Conti F; Gionfra T; Belli F; Lopez M
Oncology; 2000; 58(1):3-7. PubMed ID: 10644933
[TBL] [Abstract][Full Text] [Related]
32. Phase I study of Doxil and vinorelbine in metastatic breast cancer.
Burstein HJ; Ramirez MJ; Petros WP; Clarke KD; Warmuth MA; Marcom PK; Matulonis UA; Parker LM; Harris LN; Winer EP
Ann Oncol; 1999 Sep; 10(9):1113-6. PubMed ID: 10572612
[TBL] [Abstract][Full Text] [Related]
33. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
34. Results of a clinical phase I dose-escalation study of cytarabine in combination with fixed-dose vinorelbine, paclitaxel, etoposide and cisplatin for the treatment of relapsed/refractory lymphoma.
Lonial S; Arellano M; Hutcherson D; Langston A; Flowers C; Heffner LT; Winton E; Jo Lechowicz M; Waller EK
Leuk Lymphoma; 2006 Oct; 47(10):2155-62. PubMed ID: 17071490
[TBL] [Abstract][Full Text] [Related]
35. A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer.
Subramanyan S; Abeloff MD; Bond SE; Davidson NE; Fetting JH; Gordon GB; Kennedy MJ
Cancer Chemother Pharmacol; 1999; 43(6):497-502. PubMed ID: 10321510
[TBL] [Abstract][Full Text] [Related]
36. Docetaxel plus vinorelbine as salvage chemotherapy in advanced breast cancer: a phase II study.
Rodríguez J; Calvo E; Cortes J; Santisteban M; Perez-Calvo J; Martínez-Monge R; Brugarolas A; Fernández-Hidalgo O
Breast Cancer Res Treat; 2002 Nov; 76(1):47-56. PubMed ID: 12408375
[TBL] [Abstract][Full Text] [Related]
37. Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I results.
Holmes FA; Valero V; Walters RS; Theriault RL; Booser DJ; Gibbs H; Fraschini G; Buzdar AU; Willey J; Frye D; Asmar L; Hortobagyi GN
Ann Oncol; 1999 Apr; 10(4):403-11. PubMed ID: 10370782
[TBL] [Abstract][Full Text] [Related]
38. Combination cisplatin-vinorelbine for relapsed and chemotherapy-pretreated metastatic breast cancer.
Shamseddine AI; Taher A; Dabaja B; Dandashi A; Salem Z; El Saghir NS
Am J Clin Oncol; 1999 Jun; 22(3):298-302. PubMed ID: 10362341
[TBL] [Abstract][Full Text] [Related]
39. Phase I study of vinorelbine and carboplatin combination in patients with taxane and anthracycline pretreated advanced breast cancer.
Kosmas C; Agelaki S; Giannakakis T; Mavroudis D; Kouroussis Ch; Kalbakis K; Papadouris S; Souglakos J; Malamos N; Georgoulias V
Oncology; 2002; 62(2):103-9. PubMed ID: 11914594
[TBL] [Abstract][Full Text] [Related]
40. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
